1 The effects of lithium on [3H]-inositol and [3H]-cytidine incorporation into [3H]-inositol monophosphates ([3H]-InsP,) and [3H]-cytidine monophosphorylphosphatidate ([3H]-CMP-PA), respectively, and inositol 1,4,5-trisphosphate (InsP3) and inositol 1,3,4,5-tetrakisphosphate (InsP4) mass were studied in carbachol-stimulated human ml muscarinic receptor-transfected Chinese hamster ovary cells (ml CHO cells). 2 Lithium alone (10 mM) had no appreciable effects on any of the four parameters measured; it was only in carbachol-stimulated cells that the effects of lithium became apparent. 3 In the presence of carbachol (1 mM), lithium (10 mM) caused a relatively rapid (within 5 min) accumulation of [3H]-InsP, and [3H]-CMP-PA which continued up to about 20-30min, after which accumulation slowed down. On the other hand, the elevation in InsP3 and InsP4 levels produced by carbachol was not altered by lithium in the short-term and only at later times (>20-30min) was the response attenuated, with InsP3 and InsP4 levels approaching basal. 4 The effects of lithium on carbachol-stimulated [3H]-InsP, and [3H]-CMP-PA accumulation and the attenuation of the carbachol-induced elevation of InsP3 and InsP4 were all dose-dependent, with EC50s in the region of 1 mM. 5 The lithium-induced effects on [3H]-CMP-PA and InsP3 and InsP4 in carbachol-stimulated cells could be reversed, in a dose-dependent manner, by preincubation with exogenous myo-inositol (EC50 = 2-3 mM) but not by the inactive analogue scyllo-inositol, indicating that these effects occur as a consequence of depletion of inositol. 6 The temporal effects of lithium are consistent with lithium inhibiting inositol monophosphatase, causing accumulation of InsP1, resulting in lower free inositol levels. This leads to accumulation of CMP-PA and reduced PI synthesis which, once agonist-linked membrane inositol phospholipids are depleted, produces attenuated InsP3 and InsP4 responses. 7 These results in ml CHO cells support the hypothesis that lithium affects the PI cycle cell signalling pathway by depletion of inositol due to inhibition of inositol monophosphatase.
Introduction
It is over 40 years since the original description of the use of lithium in the treatment of manic depression (Cade, 1949 ), yet the mechanism by which lithium exerts its therapeutic effects remains uncertain. It has been proposed, however, that manic depression may be associated with hyperactivity of certain transmitter systems linked to the phosphatidylinositol (PI) signal transduction pathway and that lithium may act by inhibiting the PI cycle as a consequence of depletion of intracellular inositol, thereby reducing the hyperactivity in these transmitter systems (Berridge et al., 1982; 1989; Nahorski et al., 1991) .
According to this hypothesis, lithium inhibits inositol monophosphatase (IMPase), which is a key enzyme in the PI cycle in that it dephosphorylates inositol monophosphates (InsPj) producing inositol that can combine with cytidine monophosphorylphosphatidate (CMP-PA) to produce PI in a reaction catalysed by the enzyme PI synthase (Berridge & Irvine, 1989; Ragan, 1990) . Intracellular inositol originates either from transport into the cell via a lowor high-affinity mechanism or from dephosphorylation of InsP,, which are derived from the inositol 1,4,5-trisphosphate (InsP3) and inositol 1,3,4,5-tetrakisphosphate (InsP4) second messengers or as an intermediate in the de novo synthesis of inositol from ' Author for correspondence. glucose 6-phosphate. In cells where inositol is derived primarily from the dephosphorylation of InsP, by IMPase rather than by transport mechanisms, inhibition of IMPase effectively depletes intracellular inositol and results in reduced membrane inositol phospholipids available for signal transduction, ultimately resulting in reduced levels of InsP3 and InsP4 following stimulation.
Evidence in support of this hypothesis originates primarily from work in rat or mouse cortical slice preparations in which, under stimulated conditions, lithium results in an accumulation of InsP, (Batty & Nahorski, 1985; Kennedy et al., 1989) . There is a concomitant accumulation of CMP-PA, presumably as a result of decreased inositol concentrations (Godfrey, 1989; Kennedy et al., 1989; Nahorski et al., 1991) and an attenuation of the stimulus-dependent increase in InsP3 and InsP4 (Kennedy et al., 1989; 1990; Varney et al., 1992) .
Clearly, the effects of lithium on [3H]-InsP, and [3H]-CMP-PA, which accumulate as a direct effect of the inhibition of IMPase, should occur prior to any effects on the second messengers InsP3 and InsP4, which should occur not in parallel with the effects on [3H]-InsP, and [3H]-CMP-PA, but only after a lag interval that corresponds to the finite time required to deplete existing agonist-linked membrane inositol phospholipids. To examine the temporal effects of lithium on the PI cycle, we have measured, in Chinese hamster ovary cells transfected with the PI-linked (Fisher et al., 1992) human muscarinic ml cholinoceptor (ml CHO cells), the incorporation of [3H]-inositol into [3H]-InsP, and [3H]cytidine into [3H]-CMP-PA and, using radioreceptor binding assays, the mass of InsP3 and InsP4 second messengers. The results show that in carbachol-stimulated cells, lithium produced a relatively rapid (i.e. within 5 min) accumulation of [3H]-InsP, and [3H]-CMP-PA but that the attenuation of the carbachol-induced increase in InsP3 and InsP4 occurred only after 20-30min. These effects were all dose-dependent and their reversal by myo-but not scyllo-inositol is consistent with them being due to a depletion of inositol secondary to inhibition of IMPase.
Methods
[3H]-inositol incorporation into [3H]-InsP, The method for the incorporation of [3H]-inositol into [3H]-InsP, was a modification of methods used in the rat cortical slice preparation (Batty & Nahorski, 1985) as described in more detail elsewhere (Atack et al., 1993) . Briefly, cells were grown to confluence for 2 days in Eagles minimal essential medium (inositol concentration = 11 M) containing 10% foetal bovine serum and 0.5 jCi ml-1 . Cells were harvested (2 x 106 cells ml-') into Krebs Henseleit buffer plus 0.5 iLCi ml' [3H]-inositol. Cells (280 1tl) were then incubated at 37°C in the presence of LiCl for 30 min followed by, as required, carbachol (assay concentration = 1 mM), to give a final assay volume of 300 ftl.
Incubations were stopped by addition of 1 M trichloroacetic acid and samples were centrifuged, washed with diethyl ether and neutralised. Finally, [3H]-InsP, were separated from [3H]inositol by Dowex-formate anion exchange chromatography (Berridge et al., 1983 ).
[3H]-cytidine incorporation into [3H]-CMP-PA The method employed was modified from that of Downes & Stone (1986) . Cells were grown to confluence in 24-well plates (2 x 105 cells/well) and the medium replaced with 200 Il/well of fresh Dulbecco's minimal essential medium (inositol concentration = 40 gM) containing 3 pCi [3H]cytidine, lithium, myoor scyllo-inositol as appropriate and were incubated at 37°C for 30 min followed by stimulation with carbachol (I mM). Incubations were stopped with 1 ml chloroform:methanol (1:2 v/v) and a further 500 fl chloroform and 500 jil water added to each sample. Samples were aspirated from the wells and centrifuged at 1000 r.p.m. for O min and the upper phase removed. The lower phase was washed with 1 ml methanol: 1 M HCI (1:1 v/v). Finally, 200 ptl of lower phase was transferred to scintillation vials for counting.
Measurement of InsP3 and InsP4
Cells were grown, harvested, incubated and extracted as for the incorporation of [3H]-inositol into [3H]-InsP, except that no [3H]-inositol was included. The concentrations of InsP3 and InsP4 were measured in separate triplicate 30 IAI aliquots (total assay volume of 120 1l) of the same sample using previously published radioreceptor binding assays employing bovine adrenal and rat cerebellar membranes for InsP3 and InsP4 measurements, respectively (Challiss et al., 1988; 1990; . Protein concentrations were determined on aliquots of harvested cells by the method of Lowry et al. (1951) .
Materials
[3H]-inositol and unlabelled InsP3 and InsP4 were obtained from Amersham International plc, [3H]-InsP3 and [32P]-InsP4 were from Du Pont (UK) Ltd, Dowex formate anion exchange resin from Bio-Rad, cell culture media from Gibco and organic solvents from Fisons plc. [3H]-cytidine, carbachol, lithium chloride, myo-inositol, scyllo-inositol and all other reagents were purchased from Sigma.
Results
Time course of effects of lithium on [3H]-InsP, and
[3H]-CMP-PA accumulation [3HJ-InsP, In the presence of lithium alone (10 mM) or carbachol alone (1 mM) there was a slight elevation in InsP, levels, by about 20%, even at the earliest time points studied. This degree of increase in InsP, was maintained throughout the 60min duration of the experiment with lithium alone whereas with carbachol alone InsP, levels increased to about 40% above basal at times greater than 20min (Figure la) .
In the presence of both lithium and carbachol, there was a pronounced increase in [3H]-InsP, levels over and above levels in control (i.e. lithium-alone or carbachol-alone) by When cells were preincubated with myo-inositol (10 mM) in addition to lithium and then stimulated with carbachol, the effects were dramatic with the large increase in [3H]-CMP-PA seen with lithium and carbachol in the absence of myoinositol being abolished. However, although [3H]-CMP-PA levels were initially (up to about 2 min) around 40% lower than basal, at later time points there was a slight, progressive increase in levels to about 250% of basal by 60 min, suggesting that the reversal of the effects of lithium was about 95%. Time course of effects of lithium on InsP3 and InsP4
InsP3 Lithium alone (10 mM) had essentially no effect on InsP3 concentrations whereas carbachol alone (1 mM) rapidly produced, within 10 s, a large increase in InsP3 levels to about 300% of basal (Figure 2a ). Thereafter, InsP3 concentrations were maintained at between 200-300% of basal throughout the duration of the experiment. In the presenoe of lithium and carbachol, the short-term (< 10 min) effects (i.e. large increase in InsP3 levels) were essentially the same as in the absence of lithium. However, by 30 min lithium had clearly attenuated the increase in InsP3 caused by carbachol, with InsP3 concentrations reaching basal (Figure 2a ). The attenuation of the carbachol-induced elevation of InsP3 by lithium could be reversed by the addition of exogenous myoinositol (10 mM) with the response in lithium/carbachol/myoinositol-treated cells being the same as in cells stimulated by carbachol alone (i.e. myo-inositol cancels out the effects of lithium). Indeed, if anything, InsP3 levels were enhanced in the presence of exogenous myo-inositol (see also Lee et al., 1992) . InsP4 The effects of lithium on InsP4 (Figure 2b ) were qualitatively the same as seen with InsP3. Hence, lithium alone (10 mM) had no effect on InsP4 levels whereas carbachol alone (1 mM) produced a rapid increase in InsP4 levels to about 500% of basal within the first minute. The figures on right show 5-60 min): (0) basal (no lithium and no carbachol); (0) plus carbachol (no lithium plus stimulation with 1 mM carbachol for varying times); (U) plus lithium (preincubation for 30 min with 10 mM lithium followed by addition of buffer); (@) plus lithium and carbachol (preincubation for 30 min with 10 mm lithium and stimulation with 1 mm carbachol for varying times); (V) plus Li, carbachol and inositol (preincubation for 30 min with 10 mm lithium and 10 mM myo-inositol plus stimulation with 1 mM carbachol). Values are expressed as a percentage of basal values (averaged across the various time points) and are presented as mean ± s.e.mean (n = 7 and n = 4 for InsP3 and InsP4, respectively). Basal InsP3 and InsP4 concentrations were in the region of 30 and 10 pmol mg-' protein, respectively. Note that lithium only started to attenuate the carbachol-induced elevation of InsP3 and InsP4 after 20-30min and that this attenuation was reversed by the addition of exogenous myo-inositol (10mM).
carbachol-induced elevation of InsP4 was sustained throughout the experiment, with values varying between about 500-600% of basal. The short-term (<10 min') effects of lithium on the carbachol-stimulated increase in InsP4 were essentially negligible, but by 20 min the response to carbachol became attenuated. However, this attenuation was not as marked as with InsP3 (which reached basal levels by 30 min) with InsP4 levels approaching basal only by 60 min. Again as with InsP3, the lithium attenuation of the carbachol-induced increase in InsP4 could be reversed by myo-inositol, with the lithium/carbachol/myo-inositol time course being the same as seen with carbachol alone.
Lithium dose-response curves Figure 3 shows 
Discussion
The linearity of [3H]-InsP1 accumulation over the first 20-30min in carbachol-stimulated ml CHO cells is comparable to that seen in the rat cortical slice preparation (Gonzales & Crews, 1984; Kennedy et al., 1989) and the EC50 for this lithium-induced effect in ml CHO cells (1.2mM, Figure 3 ; in agreement with a previous report of 1 mM; Atack et al., 1993) 1984] and 0.5 and 0.3 mM for InsP, [Batty & Nahorski, 1985; Kennedy et al., 1989] ). However, the EC50 for lithium in mouse cortical slices was much lower (ca. 0.1 mM ; Whitworth & Kendall, 1988) . The reduced rate of [3H]-InsP, accumulation after about 20-30 min was also very similar to that seen in rat cortical slices (Gonzales & Crews, 1984) and in thyrotropin-releasing hormone-stimulated GH3 pituitary tumour cells (Drummond et al., 1984; Hughes & Drummond, 1987) and is consistent with reduced PI cycle activity, presumably as a consequence of inositol depletion. Unfortunately, using the present method involving [3H]-inositol prelabelling, it is not possible to address the issue of whether exogenous myo-inositol can reverse this effect (i.e. can exogenous inositol maintain stimulated PI cycle turnover resulting in a continued, linear InsP, accumulation?) since exogenous inositol would upset the established isotopic equilibrium. However, this issue could be addressed by mass measurements of InsP, isomers .
The dramatic accumulation of [3H]-CMP-PA seen in ml CHO cells resembled that seen following cholinoceptor stimulation in parotid gland slices (Downes & Stone, 1986) and rat cerebral cortex slices (Godfrey, 1989; Kennedy et al., 1990; Nahorski et al., 1991) . However, whereas in rat cortical slices (Godfrey, 1989; Kennedy et al., 1990) accumulation was immediate, there was a 2-5 min lag period in ml CHO cells whilst in parotid gland there was a slightly longer lag (Downes & Stone, 1986 ). These differences are presumably due to the different tissue preparations employed. The dosedependency of the effect of lithium on [3H]-CMP-PA accumulation in ml CHO cells (0.8 mM; Figure 3 ) was similar to that seen in the rat cortical slice preparation (0.6 mM: Godfrey, 1989; Kennedy et al., 1990) . A striking feature of the response in both ml CHO cells and the rat cortical slice preparation is the similarity between the [3H]-CMP-PA accumulation and the [3H]-InsP, accumulation i.e. 2-5 min lag in ml CHO cells and immediate response in rat cortical slices (Figure 1 and Kennedy et al., 1989; 1990) .
These data confirm that [3H]-CMP-PA accumulation is a sensitive indicator of inositol depletion caused by accumulation of [3H]-InsP, due to inhibition of IMPase (Downes & Stone, 1986; Kennedy et al., 1990; Nahorski et al., 1991) .
With respect to InsP3 and InsP4, the greater increase in InsP4 compared to InsP3 following cholinoceptor stimulation in the absence of lithium is similar to that reported in rat, mouse and guinea-pig cortical slices (Whitworth & Kendall, 1988; Kennedy et al., 1990; Nahorski et al., 1991; Lee et al., 1992) . As regards the time course of carbachol-stimulated increases in InsP3 and InsP4, there was an initial spike of InsP3 within the first min, whereas InsP4 levels rose less dramatically with no evidence of a peak within the first min. These results are in agreement with previous observations using ml CHO cells (Lambert et al., 1991b) or the human neuroblastoma cell line SH-SY5Y, which express endogenous m3 muscarinic receptors (Lambert & Nahorski, 1990; Lambert et al., 1991a) . In the presence of lithium, there was a definite lag time of about 20-30 min before lithium started to attenuate the carbachol-induced elevation in InsP3 and InsP4; at early time points, carbachol-stimulated InsP3 and InsP4 concentrations were essentially the same in the presence and absence of lithium. A similar lag period of about 10-20 min has been reported for reductions in InsP3 and InsP4 in the rat (Kennedy et al., 1989; 1990; Nahorski et al., 1991; Varney et al., 1992) and mouse (Whitworth & Kendall, 1988) cortical slice preparations. Furthermore, in electrophysiological studies, the ability of muscarinic stimulation to block the inhibitory actions of adenosine in a hippocampal preparation was inhibited by lithium only after a 10-15 min lag (Worley et al., 1988) and the densitization of carbacholinduced hippocampal cell firing was attenuated by lithium (an effect that could be reversed with 1 mM myo-inositol) only after an appreciable delay (Pontzer & Crews, 1990 ). This lag period presumably represents the time required for depletion of agonist-linked membrane inositol phospholipids after which the response to stimulation becomes reduced. The EC50 of lithium's effect on InsP3 and InsP4 levels in ml CHO cells were the same, 0.9 mM (Figure 3) , which is higher than seen in the rat cortical slice preparation for InsP3 and InsP4 (0.3 and 0.1 mM, respectively: Kennedy et al., 1989 (Figure 1) . The key aspect of this sequence of events is the reduction in free inositol available for PI synthesis as a consequence of inhibition of IMPase. If this is correct then replenishment by exogenous myo-inositol should reverse all these features (i.e. accumulation of [3H]-InsP, and [3H]-CMP-PA and attenuation of the carbachol-induced increases in InsP3 and InsP4). Although it was not possible to study the effects of myoinositol on reversal of InsP1 accumulation (see above), myoinositol was able to abolish the effect of lithium on [3H]-CMP-PA and InsP3 and InsP4. Hence, lithium-induced accumulation of [3H]-CMP-PA following cholinoceptor stimulation in ml CHO cells was almost completely reversed by addition of 10mM myo-but not scyllo-inositol with an ECs0 of 1.4 mM and the attenuation of InsP3 and InsP4 responses by lithium were reversed by myo-inositol with respective ECsos of 2.7 and 3.3 mM (Figure 4) . These results are similar to those seen in parotid gland where [3H]-CMP-PA accumulation could be restored to levels seen in the absence of lithium by 10-30 mM myo-inositol (Downes & Stones, 1986) . In cholinoceptor-stimulated rat brain slices, Godfrey (1989) observed complete reversal of lithiuminduced [3H]-CMP-PA accumulation by 10 mM myo-inositol, with an EC50 of 0.8 mM and in an autoradiographic study of [3H]-cytidine incorporation into membrane [3H]-CMP-PA, Hwang et al. (1990) reported a reversal of the effects of lithium by myo-inositol at a concentration of 20 mM. However, also in rat brain slices, Nahorski and colleagues (Kennedy et al., 1990; Nahorski et al., 1991) reported only partial reversal of lithium-induced [3H]-CMP-PA accumulation and attenuation of InsP3 and InsP4 responses by 10 and 30 mM myo-inositol (but no effect of scyllo-inositol), presumably due in these particular preparations to relatively poor transport of exogenous myo-inositol into inositol-depleted cells. The differences in responses of different tissues may, as suggested by Nahorski et al. (1991) , reflect differences in inositol reserves, inositol transport systems, resting inositol monophosphates and differences in the kinetic properties of PI synthase between tissues (e.g. different EC50 values for myo-inositol for the reversal of [3H]-CMP-PA accumulation in rat, mouse and guinea-pig cortical slice preparations: Lee et al., 1992) .
It should be emphasised that in the present study, the effects of lithium were readily observed in cells grown in low inositol concentration medium. Indeed, the validity of the hypothesis that lithium may exert its effects in vivo via its actions on PI cycle activity due to inositol depletion has recently been challenged by observations that although lithium does indeed attenuate agonist-induced increases in InsP3 and InsP4 in rat and mouse cortical slices, there is no comparable effect in guinea-pig or monkey brain cortical slices Lee et al., 1992) . These species differences were ascribed to differences in endogenous inositol levels in the different cortical slice preparations.
Clearly, in tissues in which inositol depletion can be easily achieved (e.g. rat or mouse cortical slices or ml CHO cells), the effects of lithium on PI cycle activity are readily observed. However, the key issue, highlighted by the studies of Hokin and colleagues Lee et al., 1992) , is whether sufficient inositol depletion to impair PI cycle functioning occurs in vivo. Thus, it is possible that in the brain in vivo, although free inositol levels fall after lithium administration, the decrement of about 35% (Allison & Stewart, 1971; Sherman et al., 1986) may not be sufficient to be rate-limiting in the synthesis of PI and consequently the levels of brain InsP3 and InsP4 may not be altered in vivo by lithium-treatment. However, it has recently been reported that lithium can attenuate pilocarpine-induced elevations in rat cortical InsP3 levels (Jope et al., 1992) . Moreover, this effect was observed at 60 min but not 20 min, a time course consistent with the effects seen in ml CHO cells (Figure 2 ). It therefore seems that the reduced levels of inositol in the rat cortex in vivo are indeed sufficient to impair PI-linked intracellular signalling (or at least InsP3), presumably as a consequence of reduced PI synthesis caused by inositol depletion.
In summary, we have characterized the effects of lithium on [3H]-InsP, and [3H]-CMP-PA accumulation and InsP3 and InsP4 concentrations in cholinoceptor-stimulated ml CHO cells. The effects of lithium were all dose-dependent with EC"s in the region of 1 mM, which is approximately equivalent to therapeutic plasma levels of lithium (Drummond, 1987) and also comparable to the K, for lithium vs inositol monophosphatase (Hallcher & Sherman, 1980; Gee et al., 1988; McAllister et al., 1992) . The effects of lithium on
[3H]-CMP-PA and InsP3 and InsP4 were all consistent with being due to inositol depletion since exogenous myo-but not scyllo-inositol were able to reverse these effects. These data support the hypothesis that lithium can modulate PI cycle activity due to inositol depletion as a consequence of inhibition of IMPase.
